Heart Failure and Transplant Ambulatory Care Program
Associate Professor of Medicine

E-Mail

Hospital of the University of Pennsylvania
Department of Medicine
Cardiovascular Medicine Division
6 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104-4385

Appointments

Contact: Clara Moderski (215) 615-0800

Clinical Specialty:

• Cardiovascular Medicine

Practice Location:

• Hospital of the University of Pennsylvania, 6 Penn Tower
• Penn Medicine at Radnor, 250 King of Prussia Road, Radnor, PA

Education:

• MD: Temple University
• Residency: Temple University Hospital
• Residency: Temple University Hospital

Research Interest:

• Clinical Heart Failure
• Clinical Heart Transplant

Selected Publications:

1. Brozena S, Johnson M, Ventura H, Hobbs R, Miller L, Olivari MT, Clemson B, Bourge R, Quigg R, Mills RM, Naftel D. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after cardiac transplantation. J Am Coll Cardiol 1996;27:1707-1712
2. Tenero D, Boike S, Boyle D, Ilson B, Fesniak HF, Brozena S. Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure. Journal of Clinical Pharmacology 2000 ;40:844-853
3. Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Inf Dis 2001;32:307-10
4. Israni A, Brozena S, Pankewycz O, Grossman R, Bloom R. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. American Journal of Kidney Diseases 2002;39:E16.1-5
5. Brozena, SC. Examination of the patient expected to have heart failure. In The Clinician’s Guide to Congestive Heart Failure. (Ed. M Jessup, E Loh) Humana Press, 2003.
6. Jessup M, Brozena S. Medical Progress: Heart Failure. N Eng J Med 2003;348:2007-18
7. Brozena SC, Jessup M. The new staging system for congestive heart failure: What every primary care physician should know. Geriatrics 2003;58:31-36
8. Brozena SC, Twomey C, Goldberg LR, Desai SS, Drachman B,Kao A, Popjes E, Zimmer R, Jessup M. A prospective study of continuous Intravenous milrinone therapy for Status IB patients awaiting heart transplant. J Heart Lung Transplantation 2004;23:1082-6
9. Dorbala S, Brozena S, Zeb S, Galatro K, Homel P, Ren Jian-Fang, Chaudhry FA. Risk stratification of women with peripartum cardiomyopathy at Initial presentation: a dobutamine stress echocardiographic study. J Am Soc Echocardiography 2005;18:45-48
10. Brozena SC, Shilling J, Cappola T. Exploring the extremes of ventricular remodeling in idiopathic dilated cardiomyopathy: characteristics of patients with extreme left ventricular recovery versus progression of disease. Age matters. Dose matters. Size matters. J Cardiac Failure 2006;12:S120-1